03/27/2026
The Pangea Pharmaceuticals team had a fantastic time in New York during DCAT (Drug, Chemical, & Associated Technologies Association) Week — the premier global gathering for the bio/pharmaceutical manufacturing and development community. The event provided an exceptional opportunity for meaningful one-on-one engagement with colleagues and partners across the industry. We greatly appreciated the chance to connect with many of our collaborators from around the world, including the outstanding team from Brillian Pharma who joined us from China. We’re excited to announce our upcoming launch of Sdamlo™, our powder for oral solution formulation of amlodipine, scheduled for availability this April. Featured in Photo: Anthony LaViola, CEO & Co-Founder of Pangea Pharmaceuticals and Nolan Wang, Director & CTO of Brillian Pharma.